4.7 Review

Epigenetic field cancerization in gastrointestinal cancers

Journal

CANCER LETTERS
Volume 375, Issue 2, Pages 360-366

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2016.03.009

Keywords

Epigenetic field defect; Methylation; Long interspersed nucleotide element-1; Gastrointestinal cancer; Cancerization

Categories

Funding

  1. Japan Society for the Promotion of Science (JSPS) [26713042]
  2. Grants-in-Aid for Scientific Research [26713042] Funding Source: KAKEN

Ask authors/readers for more resources

Epigenetic alterations, including aberrant DNA methylation, play an important role in human cancer development. Importantly, epigenetic alterations are reversible and can be targets for therapy or chemoprevention for various types of human cancers. A field for cancerization, or a field defect, is formed by the accumulation of genetic and/or epigenetic alterations in normal-appearing tissues and can correlate with risk of cancer development. Thus, a better understanding of epigenetic field cancerization may represent a useful translational opportunity for cancer risk assessment, including previous history and exposure to carcinogenic factors, and for cancer prevention. In this article, we summarize current knowledge regarding epigenetic field cancerization and its clinical implications in gastrointestinal cancers, including colorectal cancer, gastric cancer and esophageal cancer. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available